Suppr超能文献

GPIHBP1:一种对乳糜微粒脂解过程至关重要的内皮细胞分子。

GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons.

作者信息

Young Stephen G, Davies Brandon S J, Fong Loren G, Gin Peter, Weinstein Michael M, Bensadoun André, Beigneux Anne P

机构信息

Department of Medicine/Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA.

出版信息

Curr Opin Lipidol. 2007 Aug;18(4):389-96. doi: 10.1097/MOL.0b013e3281527914.

Abstract

PURPOSE OF REVIEW

To summarize recent data indicating that glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) plays a key role in the lipolytic processing of chylomicrons.

RECENT FINDINGS

Lipoprotein lipase hydrolyses triglycerides in chylomicrons at the luminal surface of the capillaries in heart, adipose tissue, and skeletal muscle. The endothelial cell molecule that facilitates the lipolytic processing of chylomicrons has never been clearly defined. Mice lacking GPIHBP1 manifest chylomicronemia, with plasma triglyceride levels as high as 5000 mg/dl. In wild-type mice, GPIHBP1 is expressed on the luminal surface of capillaries in heart, adipose tissue, and skeletal muscle. Cells transfected with GPIHBP1 bind both chylomicrons and lipoprotein lipase avidly.

SUMMARY

The chylomicronemia in Gpihbp1-deficient mice, the fact that GPIHBP1 is located within the lumen of capillaries, and the fact that GPIHBP1 binds lipoprotein lipase and chylomicrons suggest that GPIHBP1 is a key platform for the lipolytic processing of triglyceride-rich lipoproteins.

摘要

综述目的

总结近期数据,表明糖基磷脂酰肌醇锚定的高密度脂蛋白结合蛋白1(GPIHBP1)在乳糜微粒的脂解过程中起关键作用。

最新发现

脂蛋白脂肪酶在心脏、脂肪组织和骨骼肌毛细血管的管腔表面水解乳糜微粒中的甘油三酯。促进乳糜微粒脂解过程的内皮细胞分子一直未被明确界定。缺乏GPIHBP1的小鼠表现出乳糜微粒血症,血浆甘油三酯水平高达5000mg/dl。在野生型小鼠中,GPIHBP1在心脏、脂肪组织和骨骼肌毛细血管的管腔表面表达。转染了GPIHBP1的细胞能 avidly 结合乳糜微粒和脂蛋白脂肪酶。

总结

Gpihbp1缺陷小鼠中的乳糜微粒血症、GPIHBP1位于毛细血管管腔内这一事实以及GPIHBP1结合脂蛋白脂肪酶和乳糜微粒这一事实表明,GPIHBP1是富含甘油三酯脂蛋白脂解过程的关键平台。 (注:avidly这个词在原英文中可能有误,推测可能是avidly,这里按推测翻译为“强烈地”)

相似文献

1
GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons.
Curr Opin Lipidol. 2007 Aug;18(4):389-96. doi: 10.1097/MOL.0b013e3281527914.
4
GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins.
J Lipid Res. 2009 Apr;50 Suppl(Suppl):S57-62. doi: 10.1194/jlr.R800030-JLR200. Epub 2008 Oct 14.
5
Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution.
Biochim Biophys Acta. 2007 Dec;1771(12):1464-8. doi: 10.1016/j.bbalip.2007.10.005. Epub 2007 Oct 22.
6
GPIHBP1 and lipolysis: an update.
Curr Opin Lipidol. 2009 Jun;20(3):211-6. doi: 10.1097/MOL.0b013e32832ac026.
7
Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells.
Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):176-82. doi: 10.1161/ATVBAHA.110.214718. Epub 2010 Oct 21.
9
GPIHBP1, an endothelial cell transporter for lipoprotein lipase.
J Lipid Res. 2011 Nov;52(11):1869-84. doi: 10.1194/jlr.R018689. Epub 2011 Aug 15.
10
The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons.
J Biol Chem. 2008 Oct 24;283(43):29554-62. doi: 10.1074/jbc.M802579200. Epub 2008 Aug 18.

引用本文的文献

1
Lipoprotein lipase as a target for obesity/diabetes related cardiovascular disease.
J Pharm Pharm Sci. 2024 Jul 16;27:13199. doi: 10.3389/jpps.2024.13199. eCollection 2024.
2
A unified model for regulating lipoprotein lipase activity.
Trends Endocrinol Metab. 2024 Jun;35(6):490-504. doi: 10.1016/j.tem.2024.02.016. Epub 2024 Mar 23.
4
Estimation of Metabolic Effects upon Cadmium Exposure during Pregnancy Using Tensor Decomposition.
Genes (Basel). 2022 Sep 22;13(10):1698. doi: 10.3390/genes13101698.
5
Lipoprotein Lipase and Its Delivery of Fatty Acids to the Heart.
Biomolecules. 2021 Jul 12;11(7):1016. doi: 10.3390/biom11071016.
7
Lipoprotein lipase reaches the capillary lumen in chickens despite an apparent absence of GPIHBP1.
JCI Insight. 2017 Oct 19;2(20):96783. doi: 10.1172/jci.insight.96783.
9
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
Kidney Int. 2016 Jul;90(1):41-52. doi: 10.1016/j.kint.2016.02.026. Epub 2016 Apr 26.
10
The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking.
Open Biol. 2016 Apr;6(4):150272. doi: 10.1098/rsob.150272.

本文引用的文献

2
Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue.
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17450-5. doi: 10.1073/pnas.0604026103. Epub 2006 Nov 6.
3
A mouse monoclonal antibody specific for mouse apoB48 and apoB100 produced by immunizing "apoB39-only" mice with mouse apoB48.
Biochim Biophys Acta. 2006 Feb;1761(2):182-5. doi: 10.1016/j.bbalip.2006.02.004. Epub 2006 Mar 6.
4
APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency.
Curr Opin Lipidol. 2006 Apr;17(2):122-7. doi: 10.1097/01.mol.0000217892.00618.54.
5
Apolipoprotein AV: low concentration, high impact.
Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2445-7. doi: 10.1161/01.ATV.0000193889.65915.f9.
7
Give me A5 for lipoprotein hydrolysis!
J Clin Invest. 2005 Oct;115(10):2694-6. doi: 10.1172/JCI26712.
8
Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants.
Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2573-9. doi: 10.1161/01.ATV.0000186189.26141.12. Epub 2005 Sep 15.
9
Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism.
J Biol Chem. 2005 Jul 8;280(27):25383-7. doi: 10.1074/jbc.M501589200. Epub 2005 May 6.
10
Cellular signaling by fibroblast growth factor receptors.
Cytokine Growth Factor Rev. 2005 Apr;16(2):139-49. doi: 10.1016/j.cytogfr.2005.01.001. Epub 2005 Feb 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验